Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.
Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, Hamann S, Weimer J, Ataseven B, Darb-Esfahani S, Schem C, Mundhenke C, Khandan F, Thomssen C, Jonat W, Holzhausen HJ, von Minckwitz G, Denkert C, Bauer M.
Wenners AS, et al. Among authors: weimer j.
PLoS One. 2012;7(10):e45826. doi: 10.1371/journal.pone.0045826. Epub 2012 Oct 9.
PLoS One. 2012.
PMID: 23056218
Free PMC article.